Empagliflozin Versus Vildagliptin in CAD Patients With T2DM

Conditions: Coronary Artery Disease Interventions: Drug: Empagliflozin 10 MG; Drug: Vildagliptin 50 MG Sponsors: Damanhour University; Tanta University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials